Preferred Label : glucosylceramidase;

MeSH definition : A glycosidase that hydrolyzes a glucosylceramide to yield free ceramide plus glucose. Deficiency of this enzyme leads to abnormally high concentrations of glucosylceramide in the brain in GAUCHER DISEASE. EC 3.2.1.45.;

MeSH synonym : glucocerebrosidase; beta glucocerebrosidase; hydrolase, glucosylsphingosine glucosyl; beta-glucosidase, glucosylceramide; glucosylceramide beta-glucosidase; glucosylsphingosine glucosyl hydrolase; glucosyl hydrolase, glucosylsphingosine; acid beta-glucosidase; acid beta glucosidase; beta-glucosidase, acid; beta-glucocerebrosidase; glucocerebroside beta-glucosidase; glucocerebroside beta glucosidase; beta-glucosidase, glucocerebroside; glucosyl ceramidase; ceramidase, glucosyl; glucosylceramide beta glucosidase;

MeSH CAS label : D-Glucosyl-N-acylsphingosine glucosylhydrolase;

Registry Number MeSH : EC 3.2.1.45;

MeSH annotation : /defic: consider also GAUCHER DISEASE;

Wikipedia link : https://en.wikipedia.org/wiki/Glucosylceramidase;

Is substance : O;

UNII : EC 3.2.1.45;

Details


Main resources

You can consult :

A glycosidase that hydrolyzes a glucosylceramide to yield free ceramide plus glucose. Deficiency of this enzyme leads to abnormally high concentrations of glucosylceramide in the brain in GAUCHER DISEASE. EC 3.2.1.45.

https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00186
2014
false
false
false
Canada
French
English
summary of product characteristics
drug approval
canada
taliglucerase alfa
taliglucerase alfa
enzyme replacement therapy
recombinant proteins
adult
child
gaucher disease
taliglucerase alfa
gaucher disease, type 1
gaucher disease, type 3
rare diseases
drug evaluation
risk assessment
treatment outcome
clinical trials as topic
infusions, intravenous
glucosylceramidase
glucosylceramidase

---
https://www.ema.europa.eu/medicines/human/EPAR/Cerezyme
2012
United Kingdom
English
French
syndication feed
Contraindications, Procedure
glucosylceramidase
gaucher disease
treatment outcome
drug evaluation
powders
infusions, intravenous
glucosylceramidase
glucosylceramidase
glucosylceramidase
glucosylceramidase
adult
child
aged
pregnancy
breast feeding
glucosylceramidase
drug storage
drug labeling
drug approval
drug compounding
imiglucerase
imiglucerase
drug evaluation
package leaflet
summary of product characteristics
Contraindications, Drug

---
https://www.ema.europa.eu/medicines/human/EPAR/Vpriv
2012
United Kingdom
French
English
syndication feed
package leaflet
summary of product characteristics
drug evaluation
infusions, intravenous
gaucher disease
orphan drug production
drug approval
treatment outcome
dna, recombinant
enzyme replacement therapy
pregnancy
breast feeding
adult
child
adolescent
aged
velaglucerase alfa
glucosylceramidase
glucosylceramidase
velaglucerase alfa, human
velaglucerase alfa, human
Gaucher disease type 1

---
http://www.has-sante.fr/portail/jcms/c_1014915/vpriv
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-01/vpriv_-_ct-_9171.pdf
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-09/vpriv_ct_9171.pdf
2010
France
French
English
orphan drug production
gaucher disease
infusions, intravenous
enzyme replacement therapy
glucosylceramidase
velaglucerase alfa
recombinant proteins
treatment outcome
glucosylceramidase
velaglucerase alfa, human
glucosylceramidase
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_1046144/vpriv-velaglucerase-alpha-enzyme-de-substitution
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-01/vpriv_-_ct-_9171.pdf
2010
France
French
treatment outcome
velaglucerase alfa, human
glucosylceramidase
velaglucerase alfa, human
gaucher disease
velaglucerase alfa
enzyme replacement therapy
orphan drug production
glucosylceramidase
infusions, intravenous
glucosylceramidase
evaluation of the transparency committee
guidelines for drug use

---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=355
http://www.orpha.net/data/patho/FR/fr-gaucher.pdf
2006
France
French
gaucher disease
gaucher disease
rare diseases
child
adult
diagnosis, differential
gaucher disease
prenatal diagnosis
gaucher disease
genetic therapy
glucosylceramidase
signs and symptoms
scientific and technical information

---
http://www.has-sante.fr/portail/display.jsp?id=c_245334
2004
France
French
glucosylceramidase
gaucher disease
imiglucerase
imiglucerase
guidelines for drug use

---
Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.